RespireRx Pharmaceuticals Inc (fka RSPI)

[gfp927z]

Baal, First Cortex has to file the IND for the ADHD Phase 2b with the Psychiatric Division (hopefully filed by end of August or so, just a guess), then wait approx 30 days for a response (or if no response after 30 days, the IND is automatically approved as I understand it). Then Cortex has the choice to run the Phase 2b themselves, or license CX-717/ADHD to a BP. Odds are they'll license it to BP. A BP deal for CX-717/ADHD might conceivably occur around late '07/early '08, then it's up to the BP to do the Phase 2b and beyond.